Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1800961
PUBLISHER: IMARC | PRODUCT CODE: 1800961
Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 133 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global gastrointestinal therapeutics market size reached USD 48.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 71.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033.
Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.
The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.
Key Market Segmentation:
Breakup by Type:
- Branded
- Generic
Breakup by Route of Administration:
- Oral
- Intravenous
- Others
Breakup by Application:
- Ulcerative Colitis
- Crohn's Disease
- GERD
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.
Key Questions Answered in This Report:
- How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global gastrointestinal therapeutics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A3069
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gastrointestinal Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Branded
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Route of Administration
- 7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Ulcerative Colitis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Crohn's Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 GERD
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 AbbVie Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 AstraZeneca Plc
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bausch Health Companies Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Bayer Aktiengesellschaft
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 GlaxoSmithKline Plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Novo Nordisk A/S
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Takeda Pharmaceuticals
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
Product Code: SR112025A3069
List of Figures
- Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2024
- Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2024
- Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2024
- Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2024
- Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2024
- Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2024
- Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
- Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
- Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million USD), 2025-2033
- Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
- Table 8: Global: Gastrointestinal Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.